These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23851341)

  • 1. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
    Luo S; Li T; Wang Q; Tian R; Liu H; Fang H; Chen F; Wang H
    Anal Biochem; 2014 Oct; 463():75-81. PubMed ID: 23851341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW; Chai Q; Christian T; Stevens RC
    Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E.
    Hines HB; Kim AD; Stafford RG; Badie SS; Brueggeman EE; Newman DJ; Schmidt JJ
    Appl Environ Microbiol; 2008 Feb; 74(3):653-9. PubMed ID: 18083881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A-F Employing Taguchi Design-of-Experiments.
    von Berg L; Stern D; Weisemann J; Rummel A; Dorner MB; Dorner BG
    Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK; Singh BR
    Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
    Schmidt JJ; Stafford RG
    Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and expression of a region of vesicle associated membrane protein2 (VAMP2) gene and its use as a recombinant peptide substrate for assaying clostridial neurotoxins in contaminated biologicals.
    Moghaddam MM; Mousavi L; Shokrgozar MA; Amani J; Nazariyan S; Azari S
    Biologicals; 2010 Jan; 38(1):113-9. PubMed ID: 20005125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.
    Chen S; Wan HY
    Biochem J; 2011 Jan; 433(2):277-84. PubMed ID: 21029044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, high level expression, purification, and crystallization of the full length Clostridium botulinum neurotoxin type E light chain.
    Agarwal R; Eswaramoorthy S; Kumaran D; Dunn JJ; Swaminathan S
    Protein Expr Purif; 2004 Mar; 34(1):95-102. PubMed ID: 14766304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
    Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
    Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic vesicle chips to assay botulinum neurotoxins.
    Ferracci G; Miquelis R; Kozaki S; Seagar M; Lévêque C
    Biochem J; 2005 Nov; 391(Pt 3):659-66. PubMed ID: 16011482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level expression of the light chain of botulinum neurotoxin serotype C1 and an efficient HPLC assay to monitor its proteolytic activity.
    Rawat R; Ashraf Ahmed S; Swaminathan S
    Protein Expr Purif; 2008 Aug; 60(2):165-9. PubMed ID: 18482846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of botulinum protease for human VAMP family proteins.
    Yamamoto H; Ida T; Tsutsuki H; Mori M; Matsumoto T; Kohda T; Mukamoto M; Goshima N; Kozaki S; Ihara H
    Microbiol Immunol; 2012 Apr; 56(4):245-53. PubMed ID: 22289120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B.
    Sikorra S; Henke T; Swaminathan S; Galli T; Binz T
    J Mol Biol; 2006 Mar; 357(2):574-82. PubMed ID: 16430921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).
    Kalb SR; Baudys J; Raphael BH; Dykes JK; Lúquez C; Maslanka SE; Barr JR
    Anal Chem; 2015 Apr; 87(7):3911-7. PubMed ID: 25731972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
    Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
    J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
    Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
    Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.
    Hallis B; James BA; Shone CC
    J Clin Microbiol; 1996 Aug; 34(8):1934-8. PubMed ID: 8818885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y; Singh BR
    Protein Expr Purif; 2004 Mar; 34(1):8-16. PubMed ID: 14766296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR; Barbieri JT
    Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.